Searchable abstracts of presentations at key conferences in endocrinology

ea0013p182 | Diabetes, metabolism and cardiovascular | SFEBES2007

Insulin treatment of patients with cystic fibrosis and impaired glucose tolerance arrests the decline in pulmonary function

Drummond Russell , Carty David , Small Michael , Jones Gregory

Critical clinical changes of pulmonary function and weight occur in patients with cystic fibrosis (CF) antecedent to the development of frank Diabetes Mellitus (DM). Impaired glucose tolerance (IGT) signifies diminished Insulin secretion and increased peripheral insulin resistance, correlating with worse clinical status, under nutrition and impaired pulmonary function. Insulin therapy has been associated with improvement in anthropometric data and an arrest in decline in force...

ea0013p184 | Diabetes, metabolism and cardiovascular | SFEBES2007

Incidence, awareness and apparent symptoms of hypoglycaemia in patients with cystic fibrosis treated with insulin

Drummond Russell , Carty David , Small Michael , Jones Gregory

Diabetes Mellitus (DM) and Impaired Glucose Tolerance (IGT) in patients with cystic fibrosis(CF) signifies a six fold rise in mortality and is associated with declining pulmonary function. The pathophysiology is multifactorial but largely due to Insulinopenia which is due to global islet cell fibrosis and accompanied by loss of islet alpha cells. Insulin treatment improves weight, the bacterial milieu, and lung function but is associated with hypoglycaemia. These patients may ...

ea0013p229 | Neuroendocrinology and behaviour (including pituitary) | SFEBES2007

The effects of radiotherapy on neurocognitive function in patients treated for non-functioning pituitary adenoma

Tooze Alana , Gittoes Neil , Jones Chris , Toogood Andrew

Background: Surgery, sometimes supported by adjunctive radiotherapy (RT) are the treatments of choice for patients with non-functioning pituitary adenomas (NFA). Previous studies have implicated these treatments in deficits of cognitive function, particularly memory and executive functioning, although this research has often been confounded by the inclusion of patients with hormone producing tumours. The aim of this study was to determine the impact of RT on psychometric funct...

ea0013p258 | Reproduction | SFEBES2007

The androgen receptor CAG repeat polymorphism is associated with serum testosterone levels and obesity in men with Type 2 diabetes

Stanworth Roger , Kapoor Dheeraj , Channer Kevin , Jones T. Hugh

Men with Type 2 diabetes have a high prevalence of low testosterone levels. Testosterone replacement therapy (TRT) has been shown to improve insulin sensitivity and glycaemic control in men with Type 2 diabetes. TRT also reduces fat mass and central obesity. The androgen receptor CAG repeat polymorphism length (AR CAG) correlates positively with transcriptional activity of the receptor as well as body fat, and insulin levels in healthy men. Most studies have not found an assoc...

ea0013p337 | Thyroid | SFEBES2007

Should long-term continuous anti-thyroid drug therapy be included in the therapeutic armamentarium for hyperthyroidism?

Savage Laura , Jones Rhian , Hayat Haleema , Murray Robert

A minority of patients with hyperthyroidism resulting from relapsed Grave’s disease or autonomous nodules refuse definitive treatment with surgery or radioiodine, and request long-term anti-thyroid medication. There are few data concerning the safety and efficacy of this therapeutic modality.We performed a retrospective analysis of 13 patients (8 relapsed Grave’s disease, 5 toxic MNG), 12F, median age 60 (31–76) yrs and duration of long-te...

ea0011p124 | Clinical case reports | ECE2006

Severe thyrotoxicosis and pregnancy

Parr JH , James Jones A , Wynne K , Wahid S

A 27-year-old woman presented with severely symptomatic Graves and ophthalmopathy (FT4 49.1; TSI 53). Despite 60 mg carbimazole and 240 mg propranolol she required admission to control her symptoms and thyroid function, changing to propylthiouracil 800 mg daily with propranolol (FT4 19.9). Whilst considering thyroidectomy a 6-week pregnancy was confirmed. She relapsed (? compliance) and was admitted at 14 weeks with hyperemesis gravidarum (FT4 >77.2), which responded to an...

ea0011p392 | Diabetes, metabolism and cardiovascular | ECE2006

Testosterone replacement therapy reduces insulin resistance, and improves glycaemic control in hypogonadal men with Type 2 diabetes

Kapoor D , Goodwin E , Channer KS , Jones TH

Type 2 diabetes mellitus is associated with increased prevalence of low serum testosterone levels in men [1]. Testosterone levels in men are known to be positively correlated with insulin sensitivity and negatively with visceral obesity. We performed a double blind placebo controlled crossover study to determine the effect of testosterone treatment on insulin resistance and glycaemic control in 24 hypogonadal men (10 patients treated with insulin) above age of 30 with Type 2 d...

ea0009p2 | Diabetes and metabolism | BES2005

Rosiglitazone increases testosterone levels in hypogonadal men with Type 2 diabetes

Kapoor D , Goodwin E , Channer K , Jones T

Type 2 diabetes mellitus is associated with increased incidence of low serum testosterone levels in men. Testosterone is known to be positively correlated with insulin sensitivity. Rosiglitazone is an insulin sensitizing agent that reduces insulin resistance by binding to PPAR gamma receptor. The purpose of this study was to determine the effect of Rosiglitazone on testosterone levels in hypogonadal men with Type 2 diabetes.This study was approved by BDG...

ea0009p206 | Clinical | BES2005

Thionamide resistant thyrotoxicosis - three illustrative cases

Lee S , Kapoor D , Thomas W , Jones T

Antithyroid drug (ATD) resistant thyrotoxicosis raises difficult management issues. We describe three recent cases of apparent refractory thyrotoxicosis.Case 1: A 31 year old woman presented in July 2003 with thyrotoxicosis. Despite treatment with carbimazole (CBZ) 20 milligrams tds, serum free thyroxine (FT4) concentrations remained around 60 picomoles per litre (11-20). In October, CBZ dose was increased to 40 milligrams bd and dexamethasone 2 milligra...

ea0008p18 | Cytokines and growth factors | SFE2004

Modulation of the circulating insulin-like growth factor system in patients with gastrointestinal inflammation

Baricevic I , Nedic O , Jones DR , Nikolic JA

Insulin-like growth factors (IGFs) and their binding proteins (IGFBPs) have important metabolic roles in the human body. IGFBP-3 (40 and 45 kD glycoforms) is the most abundant in serum, whereas IGFBP-2 (34 kD) and IGFBP-1 (29 kD) are present at lower concentrations.Most inflammatory diseases of the gastrointestinal tract are characterised by a cytokine- mediated inflammatory reaction, malnutrition and catabolism. The aim of this work was to detect possib...